Ran Zheng
CIK: 0001885914
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRBU
Caribou Biosciences, Inc.
Director
Discretionary Trading P&L
Holdings
About Zheng Ran
Zheng Ran (SEC CIK 0001885914) files insider reports with the SEC as Director of Caribou Biosciences, Inc. (CRBU).
Signal8 holds 2 ownership filings by Zheng Ran, all Form 4s, filed between Feb 21, 2025 and Feb 20, 2026. Those filings report 2 transactions, from Feb 20, 2025 to Feb 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Zheng Ran's filings is in BERKELEY, CA.
Recent filings by Zheng Ran
Other insiders filing for Caribou Biosciences, Inc. (CRBU)
- Kelly Timothy P, Chief Technology Officer
- MCCLUNG BARBARA G, Chief Legal Officer
- Khan Ruhi Ahmad, Chief Business Officer
- Albertson Tina M., Chief Medical Officer
- Whiting Nancy, Director
- Sacks Natalie, Director